Discontinued — last reported Q4 '21
Geographic · Revenue
North America — Revenue
Labcorp Holdings North America — Revenue remained flat by 0.0% to $3.27B in Q4 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2021
Rolls up toTotal Revenue
How to read this metric
Higher revenue indicates strong market demand and effective service delivery, while declining revenue may signal competitive pressure, pricing headwinds, or reduced testing volumes.
Detailed definition
This metric measures the total gross income generated from clinical laboratory testing and diagnostic services within th...
Peer comparison
This is a standard top-line metric used by all publicly traded healthcare service companies to report performance by geographic or operational segment.
Metric ID:
lh_segment_north_america_revenuesHistorical Data
1 years
| FY'21 | |
|---|---|
| Value | $13.09B |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's north america — revenue?
- Labcorp Holdings (LH) reported north america — revenue of $3.27B in Q4 2021.
- What does north america — revenue mean?
- The total dollar amount of sales generated by the company's North American business.